Therefore, our study aims to evaluate the expression of Toll-like receptors (TLR-2, TLR-3, TLR-4, and TLR-9) on NK and NKT-like cells in patients with gastric cancer (GC), compare these results with healthy volunteers (HV), and investigate variants depending on the cancer subtype. This evidence concerns the gene TLR9 and gastric cancer.